{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:59:03Z","timestamp":1791316743597,"version":"4.3.1"},"reference-count":46,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Multi-disciplinary Treatment Project for Major Diseases","award":["2020 NMDTP"],"award-info":[{"award-number":["2020 NMDTP"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M720093"],"award-info":[{"award-number":["2022M720093"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Chest Hospital Basic Research Project","award":["2023YNKT-1"],"award-info":[{"award-number":["2023YNKT-1"]}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["CCTS-202204"],"award-info":[{"award-number":["CCTS-202204"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["CCTS-202304"],"award-info":[{"award-number":["CCTS-202304"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32261143731"],"award-info":[{"award-number":["32261143731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030045"],"award-info":[{"award-number":["82030045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241227"],"award-info":[{"award-number":["82241227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303716"],"award-info":[{"award-number":["82303716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,4,18]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients with small cell lung cancer (SCLC) generally have a poor prognosis, with an exceptionally high proliferative rate and a strong propensity for early metastasis, indicating the urgent need for novel therapies. The development of chimeric antigen receptor (CAR)s targeting solid tumors is limited owing to the lack of target antigens and low efficacy. In this study, we aimed to discover new targets for SCLC CAR-T therapy and develop CAR-T-based combinational treatment against SCLC in preclinical models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The in vitro antitumor activity of B7H6-specific CAR-T cell was evaluated. Venetoclax-resistant B7H6 CAR-T cell were designed and the synergistic effect of venetoclax and B7-H6 CAR-T cells was tested in vitro and in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Result<\/jats:title>\n                  <jats:p>B7H6 is highly expressed in SCLC tumors. CAR-T cell against B7H6 displayed antigen-specific antitumor efficacy. BCL-2(D103E)-expressing CAR-T cells showed resistance to venetoclax-induced apoptosis. The combinational treatment of venetoclax and BCL-2(D103E)-expressing B7H6-targeting showed potent anti-SCLC effect in vitro and in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings suggest that the combination of BCL-2 mutant-expressing B7H6-targeting CAR-T cells and venetoclax could be a promising novel strategy against B7H6-expressing SCLCs and other solid tumors, providing the foundation for CAR-T cells and proapoptotic small molecules therapy in patients with SCLCs in a clinical trial.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2024-010073","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T02:10:16Z","timestamp":1746670216000},"page":"e010073","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer"],"prefix":"10.1136","volume":"13","author":[{"given":"Huihui","family":"Zhang","sequence":"first","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliang","family":"Xia","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Xuzhang","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanlin","family":"Li","sequence":"additional","affiliation":[{"name":"Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cheng","sequence":"additional","affiliation":[{"name":"Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Wang","sequence":"additional","affiliation":[{"name":"Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincheng","family":"Zong","sequence":"additional","affiliation":[{"name":"Faculty of Art & Science, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-8206","authenticated-orcid":false,"given":"Xuanming","family":"Yang","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Joint International Research Laboratory of Metabolic and Developmental Sciences, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Department of Gynaecology and Obstetrics, Shanghai Pudong New Area people\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-7262","authenticated-orcid":false,"given":"Shun","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Lung Cancer Center, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"2025100305165890000_13.5.e010073.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.034"},{"key":"2025100305165890000_13.5.e010073.2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6176-0_18"},{"key":"2025100305165890000_13.5.e010073.3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/14712598.2019.1592155","article-title":"Immunotherapy for small cell lung cancer: mechanisms of resistance","volume":"19","author":"Hamilton","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"2025100305165890000_13.5.e010073.4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00408-021-00486-y","article-title":"Update 2021: Management of Small Cell Lung Cancer","volume":"199","author":"Tariq","year":"2021","journal-title":"Lung"},{"key":"2025100305165890000_13.5.e010073.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30098-5"},{"key":"2025100305165890000_13.5.e010073.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32222-6"},{"key":"2025100305165890000_13.5.e010073.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064"},{"key":"2025100305165890000_13.5.e010073.8","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz453.003","article-title":"LBA2 First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC: Safety, pharmacokinetics (PK) and immunogenicity in CASPIAN","volume":"30","author":"\u00d6zg\u00fcro\u011flu","year":"2019","journal-title":"Ann Oncol"},{"key":"2025100305165890000_13.5.e010073.9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2019.03.028","article-title":"Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017","volume":"131","author":"Lattuca-Truc","year":"2019","journal-title":"Lung Cancer (Auckl)"},{"key":"2025100305165890000_13.5.e010073.10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025100305165890000_13.5.e010073.11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcyt.2020.01.008","article-title":"Efficacy and toxicity for CD22\/CD19 chimeric antigen receptor T-cell therapy in patients with relapsed\/refractory aggressive B-cell lymphoma involving the gastrointestinal tract","volume":"22","author":"Zeng","year":"2020","journal-title":"Cytotherapy"},{"key":"2025100305165890000_13.5.e010073.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226"},{"key":"2025100305165890000_13.5.e010073.13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166028","article-title":"IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models","volume":"133","author":"Jaspers","year":"2023","journal-title":"J Clin Invest"},{"key":"2025100305165890000_13.5.e010073.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0187-2"},{"key":"2025100305165890000_13.5.e010073.15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1078-0432.CCR-22-2293","article-title":"Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2025100305165890000_13.5.e010073.16","doi-asserted-by":"crossref","first-page":"120709","DOI":"10.1016\/j.lfs.2022.120709","article-title":"The potential of B7-H6 as a therapeutic target in cancer immunotherapy","volume":"304","author":"Mohammadi","year":"2022","journal-title":"Life Sci"},{"key":"2025100305165890000_13.5.e010073.17","doi-asserted-by":"crossref","first-page":"37435","DOI":"10.18632\/oncotarget.16391","article-title":"High expression of B7-H6 in human glioma tissues promotes tumor progression","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"2025100305165890000_13.5.e010073.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-020-0341-9","article-title":"Positive staining of the immunoligand B7-H6 in abnormal\/transformed keratinocytes consistently accompanies the progression of cervical cancer","volume":"21","author":"Gutierrez-Silerio","year":"2020","journal-title":"BMC Immunol"},{"key":"2025100305165890000_13.5.e010073.19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/gt.2015.29","article-title":"B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity","volume":"22","author":"Wu","year":"2015","journal-title":"Gene Ther"},{"key":"2025100305165890000_13.5.e010073.20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402517"},{"key":"2025100305165890000_13.5.e010073.21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jtho.2021.03.011","article-title":"Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC","volume":"16","author":"Thomas","year":"2021","journal-title":"J Thorac Oncol"},{"key":"2025100305165890000_13.5.e010073.22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.21037\/atm-20-2548","article-title":"Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"key":"2025100305165890000_13.5.e010073.23","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060528","article-title":"PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer","volume":"13","author":"Khan","year":"2024","journal-title":"Cells"},{"key":"2025100305165890000_13.5.e010073.24","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16078","article-title":"Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy","volume":"8","author":"Inoue-Yamauchi","year":"2017","journal-title":"Nat Commun"},{"key":"2025100305165890000_13.5.e010073.25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1119"},{"key":"2025100305165890000_13.5.e010073.26","doi-asserted-by":"crossref","unstructured":"Cang SD , Iragavarapu C , Savooji J , et al . ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. J Hematol Oncol 2015;8. doi:10.1186\/s13045-015-0224-3","DOI":"10.1186\/s13045-015-0224-3"},{"key":"2025100305165890000_13.5.e010073.27","doi-asserted-by":"crossref","unstructured":"Korell F , Olson ML , Salas-Benito D , et al . Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics. Sci Transl Med 2024;16. doi:10.1126\/scitranslmed.adk7640","DOI":"10.1126\/scitranslmed.adk7640"},{"key":"2025100305165890000_13.5.e010073.28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1606"},{"key":"2025100305165890000_13.5.e010073.29","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1158\/2159-8290.CD-21-1026","article-title":"Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer","volume":"12","author":"Lee","year":"2022","journal-title":"Cancer Discov"},{"key":"2025100305165890000_13.5.e010073.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004205"},{"key":"2025100305165890000_13.5.e010073.31","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1283032"},{"key":"2025100305165890000_13.5.e010073.32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103495"},{"key":"2025100305165890000_13.5.e010073.33","doi-asserted-by":"crossref","unstructured":"Zhang H , Li F , Cao J , et al . A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity. Sci Transl Med 2021;13. doi:10.1126\/scitranslmed.aba7308","DOI":"10.1126\/scitranslmed.aba7308"},{"key":"2025100305165890000_13.5.e010073.34","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11110580","article-title":"Production and Application of Multicistronic Constructs for Various Human Disease Therapies","volume":"11","author":"Shaimardanova","year":"2019","journal-title":"Pharmaceutics"},{"key":"2025100305165890000_13.5.e010073.35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/cancers13020197","article-title":"Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025100305165890000_13.5.e010073.36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00262-018-2124-1","article-title":"Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression","volume":"67","author":"Gacerez","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"2025100305165890000_13.5.e010073.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-018-0012-7"},{"key":"2025100305165890000_13.5.e010073.38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjpp-2016-0079","article-title":"The role of cancer stem cells in tumor heterogeneity and resistance to therapy","volume":"95","author":"Konrad","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"2025100305165890000_13.5.e010073.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100695"},{"key":"2025100305165890000_13.5.e010073.40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s43018-023-00709-6","article-title":"Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial","volume":"5","author":"Bagley","year":"2024","journal-title":"Nat Cancer"},{"key":"2025100305165890000_13.5.e010073.41","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0407"},{"key":"2025100305165890000_13.5.e010073.42","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011287"},{"key":"2025100305165890000_13.5.e010073.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.10.009"},{"key":"2025100305165890000_13.5.e010073.44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1061186X.2020.1797050","article-title":"Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer","volume":"29","author":"Yu","year":"2021","journal-title":"J Drug Target"},{"key":"2025100305165890000_13.5.e010073.45","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3090"},{"key":"2025100305165890000_13.5.e010073.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0495-5"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-010073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:17:13Z","timestamp":1759493833000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-010073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,7]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/jitc-2024-010073"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-010073","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}